This page lists the radiation oncology hospitals in our directory offering CAR T-Cell Therapy in Hyderabad, India, including KIMS Hospitals, Secunderabad, Yashoda Hospitals, Secunderabad, Apollo Hospital DRDO, Apollo Hospitals, Jubilee Hills. Each listing links through to the hospital's full profile page.
Ask us about car t-cell therapy in Hyderabad, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 4 accredited hospitals for Radiation Oncology in Hyderabad, India
🇮🇳 KIMS Hospitals, Secunderabad
Patients considering car t-cell therapy can be cared for by KIMS Hospitals, Secunderabad's care team in Hyderabad, India, from initial consultation through recovery. KIMS Hospitals, Secunderabad, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.
🇮🇳 Yashoda Hospitals, Secunderabad
Patients considering car t-cell therapy can be cared for by Yashoda Hospitals, Secunderabad's care team in Secunderabad, Hyderabad, India, from initial consultation through recovery. Yashoda Hospitals, Secunderabad, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.
🇮🇳 Apollo Hospital DRDO
Patients considering car t-cell therapy can be cared for by Apollo Hospital DRDO's care team in Kanchan Bagh, Hyderabad, India, from initial consultation through recovery. Apollo Hospital DRDO, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.
🇮🇳 Apollo Hospitals, Jubilee Hills
Patients considering car t-cell therapy can be cared for by Apollo Hospitals, Jubilee Hills's care team in Hyderabad, India, from initial consultation through recovery. Apollo Hospitals, Jubilee Hills, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing car t-cell therapy.
How we selected these hospitals
A hospital appears on this page when Radiation Oncology is among its listed specialties and it is located in Hyderabad, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for CAR T-Cell Therapy in Hyderabad, India?
Choosing the right hospital for car t-cell therapy is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include radiation oncology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding CAR T-Cell Therapy
CAR T-Cell Therapy (Chimeric Antigen Receptor T-Cell Therapy) is a groundbreaking, personalized immunotherapy that genetically engineers a patient's own T-lymphocytes to recognize and destroy cancer cells with precision unmatched by conventional chemotherapy or radiation.
Clinical Overview
- CAR T-Cell Therapy represents a paradigm shift in the treatment of hematological malignancies and is increasingly being explored in solid tumors.
- The process begins with leukapheresis—collecting a patient's T-lymphocytes from peripheral blood—which are then sent to a Good Manufacturing Practice (GMP)-certified laboratory where they are retrovirally or lentivirally transduced to express a chimeric antigen receptor on their surface.
- This receptor is engineered to bind a specific tumor antigen (most commonly CD19 for B-cell malignancies, BCMA for multiple myeloma, or CD22 as an emerging target) with high affinity, bypassing the need for MHC-mediated antigen presentation that cancer cells frequently downregulate to evade immunity.
Who is a Candidate?
- ELIGIBLE DIAGNOSES: Relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after ≥2 prior lines of systemic therapy; R/R follicular lymphoma (grade 3B); R/R mantle cell lymphoma; R/R B-cell acute lymphoblastic leukemia (B-ALL) in pediatric and young adult patients (up to age 25); R/R multiple myeloma after ≥4 prior lines (including a proteasome inhibitor, immunomodulatory agent, and anti-CD38 antibody).
- PERFORMANCE STATUS: ECOG performance status 0–2; Karnofsky Performance Score ≥60%.
- ORGAN FUNCTION REQUIREMENTS (ELIGIBILITY THRESHOLD): Creatinine clearance ≥45 mL/min (CKD-EPI formula); ALT/AST ≤5× ULN; total bilirubin ≤2× ULN; LVEF ≥50% confirmed on 2D Echocardiography (ECHO) or MUGA scan; no active Grade ≥3 pulmonary dysfunction (baseline O₂ saturation ≥92% on room air).
- REQUIRED DIAGNOSTIC WORKUP BEFORE TRAVEL: Whole-body PET-CT scan (FDG) within 4 weeks; bilateral bone marrow biopsy with flow cytometry and cytogenetics; complete blood count with differential and comprehensive metabolic panel; serum protein electrophoresis and immunofixation (for myeloma); HLA typing (for allogeneic considerations); infectious disease panel (HIV Ag/Ab, Hepatitis B surface Ag and core Ab, Hepatitis C Ab, CMV IgG/IgM, EBV VCA IgG, quantitative CMV PCR); cardiac ECHO; pulmonary function tests (FEV1, DLCO); MRI brain (to rule out CNS disease or ICANS risk factors); prior treatment records including all chemotherapy regimens, radiation fields, stem cell transplant history.
- +2 more
Treatment Options & Approaches
- CAR T-Cell Therapy is not a single procedure but a multi-step biological manufacturing and clinical delivery process.
- The following approaches and product categories are available at partner centers in India and the UAE:
Recovery
- PHASE 1 — PRE-TRAVEL CONSULTATION (2–4 weeks before departure):
Risks to be aware of
- CAR T-Cell Therapy carries a distinct and serious toxicity profile that patients and caregivers must understand thoroughly before initiating treatment.
- Cytokine Release Syndrome (CRS) is the most common acute toxicity, occurring in 57–93% of patients depending on the product and disease burden; Grade 3–4 CRS (severe hypotension, Grade 3+ hypoxia requiring high-flow oxygen or mechanical ventilation) occurs in 13–22% of cases and requires ICU-level management including vasopressors and tocilizumab.
Why GAF Healthcare
- GAF Healthcare provides a fully integrated, end-to-end logistics infrastructure designed specifically for the complexity of CAR T-Cell therapy, where timing, proximity to the treatment center, and rapid access to emergency care during the post-infusion monitoring period are non-negotiable.
Cost Range for Related Procedures
Common questions about CAR T-Cell Therapy
What is the cost of CAR T-Cell Therapy in India vs the UAE?
How long do I need to stay in the country before I am fit to fly home after CAR T-Cell Therapy?
What is the success rate of CAR T-Cell Therapy?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for CAR T-Cell Therapy in Hyderabad, India
Discover the Top Hospitals for CAR T-Cell Therapy in Hyderabad, India
This page lists 4 accredited radiation oncology hospitals in Hyderabad, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about car t-cell therapy in Hyderabad, India
How many radiation oncology hospitals are listed in Hyderabad, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there radiation oncology hospitals for this in other India cities?
Are these hospitals internationally accredited?
Can I get a treatment plan and cost estimate before I travel?
Do you help with visa, travel and accommodation?
What support do I get during and after treatment?
What does the "Featured" label next to a hospital's name mean?
How do I get matched with the right hospital for car t-cell therapy?
Does the listed cost cover everything?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for car t-cell therapy in Hyderabad, India.
Contact us to report an inaccuracy on this page.